https://www.grassley.senate.gov/news/news-releases/grassley-wyden-warn-pbm-cooperate-insulin-investigation-or-face-subpoena
Americans are demanding answers from PBMs and pharmaceutical companies, and we expect your company to begin providing them promptly,” Grassley and Wyden wrote. “Cigna has failed to even attempt to answer many of the questions we posed.”
“Your failure to comply with the Committee’s requests has reached an endpoint,” Grassley and Wyden concluded.